VIGABATRIN Recall D-0220-2024
Description: Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53
VIGABATRIN Recall D-0220-2024 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0220-2024 |
Event ID | 93422 |
Brand | VIGABATRIN |
Generic Name | VIGABATRIN |
Manufacturer | VIGABATRIN |
Original Package? | 1 |
Active Substance | VIGABATRIN |
Drug Route | ORAL |
Distribution | Nationwide within the United States |
Quantity | 1240 boxes |
Recall Reason | Defective Container: powder may leak out of the pouch |
Drug Classification | Class I |
Drug Code Info | 20240117 |
Product NDC | 69097-964 |
Product NUI | N0000175753 |
Pharma Class (EPC) | Anti-epileptic Agent [EPC] |
Recall Initiation Date | 20231117 |
Report Date | 20240117 |
Classification Date | 20240108 |
Address | 550 S Research Pl Central Islip, NY 11722-4415 United States |
Recalling Firm | InvaGen Pharmaceuticals, Inc. |
Initial Notification | Letter |
Unique Ingredient Identifier | GR120KRT6K |
Drug Application Number | ANDA211592 |
Structured Product Labeling (SPL ID) | 4cdad60f-7614-47cb-8594-3c0257e55c28 |
Structured Product Labeling (SPL Set ID) | 823cc915-0350-4780-85ed-cd1c338e429d |
Similar To |